The results revealed that in KIRP, LIHC, and LUAD, EIF3M expression levels exhibited a positive correlation trend with tumor Stage, whereas EIF3M expression was significantly lower in advanced-stage SKCM patients compared to early-stage cases. This evidence concerns the gene EIF3M and neoplasm.